JNP
Juniper Pharmaceuticals, Inc. Common Stock
JNP
JNP
Delisted
JNP was delisted on the 13th of August, 2018.
38 hedge funds and large institutions have $16.8M invested in Juniper Pharmaceuticals, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
15% less capital invested
Capital invested by funds: $19.9M → $16.8M (-$3.04M)
Holders
38
Holding in Top 10
–
Calls
$298K
Puts
$203K
Top Buyers
| 1 | +$3.12M | |
| 2 | +$475K | |
| 3 | +$285K | |
| 4 |
Renaissance Technologies
New York
|
+$262K |
| 5 |
AG
Algert Global
San Francisco,
California
|
+$115K |
Top Sellers
| 1 | -$1.28M | |
| 2 | -$227K | |
| 3 | -$116K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$99.6K |
| 5 |
GF
Gabelli Funds
Rye,
New York
|
-$56.2K |